Device Week – Episode 21
This article was originally published in The Gray Sheet
Executive Summary
On this week's podcast, we discussed FDA's efforts to issue a new draft guidance on 510(k) modifications, study implications for recent "leaflet motion" findings for heart valve replacements, a need for assays to guide anticoagulant therapy, a Theranos update and efforts on the Hill to reform diagnostics regulation.